Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced its 2025 interim report for the period ending June 30, 2025. The company plans to distribute an interim cash dividend of RMB0.40 per share, totaling RMB650,316,379.60. This decision reflects the company’s commitment to returning value to its shareholders. The financial reports were prepared according to China Accounting Standards and were unaudited.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$21.70 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company with limited liability established in the People’s Republic of China. The company operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
Average Trading Volume: 1,599,749
Technical Sentiment Signal: Buy
Current Market Cap: HK$45B
For an in-depth examination of 0874 stock, go to TipRanks’ Overview page.